论文部分内容阅读
For 50 years ago was introduced L-3,4-dihydroxyphenylalanine(L-dopa) in Parkinson's disease treatment and during this significant advances has been done but what trigger the degeneration of the nigrostriatal system remain unknown. There is a general a